Caroline Trotter

Summary

Affiliation: University of Bristol
Country: UK

Publications

  1. pmc Seroprevalence of bactericidal and anti-outer membrane vesicle antibodies to Neisseria meningitidis group B in England
    Caroline Trotter
    Department of Social Medicine, University of Bristol, Canynge Hall, Whiteladies Road, Bristol BS8 2PR, United Kingdom
    Clin Vaccine Immunol 14:863-8. 2007
  2. pmc Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs
    Caroline L Trotter
    Department of Social Medicine, University of Bristol, Canynge Hall, Bristol, UK
    Expert Rev Vaccines 8:851-61. 2009
  3. pmc Introducing vaccination against serogroup B meningococcal disease: an economic and mathematical modelling study of potential impact
    Hannah Christensen
    School of Social and Community Medicine, University of Bristol, Bristol, UK
    Vaccine 31:2638-46. 2013
  4. pmc Seroprevalence of bactericidal, specific IgG antibodies and incidence of meningitis due to group A Neisseria meningitidis by age in Burkina Faso 2008
    Caroline L Trotter
    School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom
    PLoS ONE 8:e55486. 2013
  5. pmc Seroprevalence of serum bactericidal antibodies against group W135 and Y meningococci in England in 2009
    Caroline L Trotter
    School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom
    Clin Vaccine Immunol 19:219-22. 2012
  6. ncbi request reprint Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae
    Caroline L Trotter
    Department of Social Medicine, University of Bristol, Canynge Hall, Whiteladies Road, Bristol, BS8 2PR, UK
    Vaccine 26:4434-45. 2008
  7. pmc Increasing hospital admissions for pneumonia, England
    Caroline L Trotter
    University of Bristol, Bristol, UK
    Emerg Infect Dis 14:727-33. 2008
  8. ncbi request reprint Meningococcal carriage in the African meningitis belt
    Caroline L Trotter
    Department of Social Medicine, University of Bristol, Bristol, UK
    Lancet Infect Dis 7:797-803. 2007
  9. pmc Seroprevalence of antibodies against serogroup C meningococci in England in the postvaccination era
    Caroline L Trotter
    Department of Social Medicine, University of Bristol, Bristol, UK
    Clin Vaccine Immunol 15:1694-8. 2008
  10. pmc Secular trends in prostate cancer mortality, incidence and treatment: England and Wales, 1975-2004
    Sabina Hussain
    Department of Social Medicine, University of Bristol, Bristol, UK
    BJU Int 101:547-55. 2008

Detail Information

Publications29

  1. pmc Seroprevalence of bactericidal and anti-outer membrane vesicle antibodies to Neisseria meningitidis group B in England
    Caroline Trotter
    Department of Social Medicine, University of Bristol, Canynge Hall, Whiteladies Road, Bristol BS8 2PR, United Kingdom
    Clin Vaccine Immunol 14:863-8. 2007
    ..With the exception of children aged 3 to 11 months, there was no clear relationship between disease incidence and seroprevalence...
  2. pmc Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs
    Caroline L Trotter
    Department of Social Medicine, University of Bristol, Canynge Hall, Bristol, UK
    Expert Rev Vaccines 8:851-61. 2009
    ..The magnitude of the herd effects following MCC vaccination was largely unanticipated, and has important consequences for the design and evaluation of new meningococcal vaccines...
  3. pmc Introducing vaccination against serogroup B meningococcal disease: an economic and mathematical modelling study of potential impact
    Hannah Christensen
    School of Social and Community Medicine, University of Bristol, Bristol, UK
    Vaccine 31:2638-46. 2013
    ....
  4. pmc Seroprevalence of bactericidal, specific IgG antibodies and incidence of meningitis due to group A Neisseria meningitidis by age in Burkina Faso 2008
    Caroline L Trotter
    School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom
    PLoS ONE 8:e55486. 2013
    ..We investigated serological correlates of protection against Neisseria meningitidis serogroup A (NmA) in Burkina Faso before the introduction of NmA conjugate vaccine...
  5. pmc Seroprevalence of serum bactericidal antibodies against group W135 and Y meningococci in England in 2009
    Caroline L Trotter
    School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom
    Clin Vaccine Immunol 19:219-22. 2012
    ..6; 95% CI, 5.9, 12.7). Unlike seroprevalence against group B meningococci, there was not an obvious peak in SBA titers in samples from teenagers. Natural immunity against group W135 and Y meningococci in England appears to be low...
  6. ncbi request reprint Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae
    Caroline L Trotter
    Department of Social Medicine, University of Bristol, Canynge Hall, Whiteladies Road, Bristol, BS8 2PR, UK
    Vaccine 26:4434-45. 2008
    ..The aim of this paper is to review the state of the current evidence on conjugate vaccines and to identify important areas for further study, in order to inform the debate regarding the best use of these vaccines...
  7. pmc Increasing hospital admissions for pneumonia, England
    Caroline L Trotter
    University of Bristol, Bristol, UK
    Emerg Infect Dis 14:727-33. 2008
    ..It may be attributable to other population factors, changes in HES coding, changes to health service organization, other biologic phenomenon, or a combination of these effects...
  8. ncbi request reprint Meningococcal carriage in the African meningitis belt
    Caroline L Trotter
    Department of Social Medicine, University of Bristol, Bristol, UK
    Lancet Infect Dis 7:797-803. 2007
    ..Carefully designed carriage studies are needed to measure and interpret the impact of meningococcal group A conjugate vaccines in Africa...
  9. pmc Seroprevalence of antibodies against serogroup C meningococci in England in the postvaccination era
    Caroline L Trotter
    Department of Social Medicine, University of Bristol, Bristol, UK
    Clin Vaccine Immunol 15:1694-8. 2008
    ....
  10. pmc Secular trends in prostate cancer mortality, incidence and treatment: England and Wales, 1975-2004
    Sabina Hussain
    Department of Social Medicine, University of Bristol, Bristol, UK
    BJU Int 101:547-55. 2008
    ....
  11. doi request reprint Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: England and Wales, 1996-2006
    Caroline L Trotter
    Department of Social Medicine, University of Bristol, Canynge Hall, UK
    J Infect 60:200-8. 2010
    ..To describe the epidemiology of invasive pneumococcal disease (IPD) in England & Wales in the pre-conjugate vaccine era...
  12. doi request reprint Meningococcal carriage by age: a systematic review and meta-analysis
    Hannah Christensen
    School of Social and Community Medicine, University of Bristol, Bristol, UK
    Lancet Infect Dis 10:853-61. 2010
    ..Previous studies have shown that carriage rates vary by age and setting; however, few have assessed carriage across all ages. We aimed to estimate the age-specific prevalence of meningococcal carriage...
  13. ncbi request reprint Barriers and facilitators to HPV vaccination of young women in high-income countries: a qualitative systematic review and evidence synthesis
    Harriet Batista Ferrer
    School of Social and Community Medicine, University of Bristol, Bristol BS8 2PS, UK
    BMC Public Health 14:700. 2014
    ..Understanding factors affecting decision-making of HPV vaccination of young women is important so that effective interventions can be developed which address barriers to uptake in population groups less likely to receive the HPV vaccine...
  14. ncbi request reprint Examining inequalities in the uptake of the school-based HPV vaccination programme in England: a retrospective cohort study
    Harriet Fisher
    School of Social and Community Medicine, University of Bristol, Bristol BS8 2PS, UK
    J Public Health (Oxf) 36:36-45. 2014
    ..This study aimed to investigate factors associated with HPV vaccine initiation and completion within the routine HPV vaccination programme in the South West of England...
  15. doi request reprint Could a peer-led intervention increase uptake of chlamydia screening? A proof of principle pilot study
    Jessica Loaring
    School of Social and Community Medicine, University of Bristol, Bristol and Trainee Clinical Psychologist, School of Psychology, University of Birmingham, Birmingham, UK
    J Fam Plann Reprod Health Care 39:21-8. 2013
    ..Peer-led approaches may increase screening uptake but their feasibility and acceptability to young people is not known...
  16. ncbi request reprint Trends in admissions to hospital involving an assault using a knife or other sharp instrument, England, 1997-2005
    Roy Maxwell
    Department of Social Medicine, University of Bristol, Canynge Hall, Bristol BS8 2PR, UK
    J Public Health (Oxf) 29:186-90. 2007
    ..Main outcome measure All completed hospital admissions with a mention of assault by sharp object (International Classification of Diseases, Tenth Revision, code X99) in the relevant diagnosis fields in HES...
  17. ncbi request reprint Fatal outcome from meningococcal disease--an association with meningococcal phenotype but not with reduced susceptibility to benzylpenicillin
    Caroline L Trotter
    Immunisation Division, PHLS Communicable Disease Surveillance Centre, London, UK
    J Med Microbiol 51:855-60. 2002
    ..No association was found between reduced penicillin susceptibility and fatal outcome, but the increasing frequency of isolates less susceptible to penicillin highlights the need for continued surveillance...
  18. pmc Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis
    Mary E Ramsay
    Public Health Laboratory Service Communicable Disease Surveillance Centre, London, NW9 5EQ
    BMJ 326:365-6. 2003
  19. ncbi request reprint Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction
    Caroline L Trotter
    Statistics, Economics, and Modelling Department, Health Protection Agency Communicable Disease Surveillance Centre, 61 Colindale Avenue, London NW9 5EQ, UK
    Lancet 364:365-7. 2004
    ..The number of individuals in these cohorts remains low, but alternative routine immunisation schedules should be considered to ensure high levels of protection are sustained...
  20. pmc Trends in Haemophilus influenzae type b infections in adults in England and Wales: surveillance study
    Jodie McVernon
    Immunisation Department, Health Protection Agency Communicable Disease Surveillance Centre, London NW9 5EQ
    BMJ 329:655-8. 2004
    ..To describe invasive Haemophilus influenzae type b (Hib) infections in individuals aged 15 years or older in England and Wales between 1991 and 2003...
  21. ncbi request reprint Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination
    Caroline L Trotter
    Modelling and Economics Unit, Centre for Infections, Health Protection Agency, London, United Kingdom
    Am J Epidemiol 162:89-100. 2005
    ..This model can be used to help predict the potential impact of vaccine strategies both in the United Kingdom and elsewhere...
  22. pmc Modelling cost effectiveness of meningococcal serogroup C conjugate vaccination campaign in England and Wales
    Caroline L Trotter
    Immunisation Division, PHLS Communicable Disease Surveillance Centre, London NW9 5EQ
    BMJ 324:809. 2002
    ..To assess the cost effectiveness of a meningococcal serogroup C conjugate vaccination campaign in 0-17 year olds...
  23. ncbi request reprint Reassessing the cost-effectiveness of meningococcal serogroup C conjugate (MCC) vaccines using a transmission dynamic model
    Caroline L Trotter
    Modelling and Economics Unit, Centre for Infections, Health Protection Agency, 61 Colindale Avenue, London, NW95EQ, UK
    Med Decis Making 26:38-47. 2006
    ..The latter effect was not accounted for in the previous economic analysis of the MCC program...
  24. ncbi request reprint Epidemiology of meningococcal disease in England and Wales 1993/94 to 2003/04: contribution and experiences of the Meningococcal Reference Unit
    Stephen J Gray
    Meningococcal Reference Unit, Health Protection Agency, Manchester Medical Microbiology Partnership, Manchester Royal Infirmary, Manchester M13 9WZ, UK
    J Med Microbiol 55:887-96. 2006
    ....
  25. ncbi request reprint No evidence for capsule replacement following mass immunisation with meningococcal serogroup C conjugate vaccines in England and Wales
    Caroline L Trotter
    Lancet Infect Dis 6:616-7; author reply 617-8. 2006
  26. ncbi request reprint Modeling future changes to the meningococcal serogroup C conjugate (MCC) vaccine program in England and Wales
    Caroline L Trotter
    Immunisation Department, Health Protection Agency Centre for Infections, London, UK
    Hum Vaccin 2:68-73. 2006
    ..The inclusion of a booster dose is likely to improve the impact of the MCC program and reducing the number of doses in infancy will improve cost-effectiveness and create space in the schedule for the addition of other vaccines...
  27. ncbi request reprint A surveillance network for meningococcal disease in Europe
    Caroline L Trotter
    Immunization Department, Health Protection Agency Centre for Infections, London, UK
    FEMS Microbiol Rev 31:27-36. 2007
    ..The importance of close collaboration between networks of epidemiologists, microbiologists, and the wider scientific and public health community is demonstrated...
  28. ncbi request reprint Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines
    Caroline L Trotter
    Immunization Department, Health Protection Agency Centre for Infections, London, UK
    FEMS Microbiol Rev 31:101-7. 2007
    ..This paper outlines recommendations on the use of conjugate vaccines in Europe based on the experience with meningococcal C conjugate (MCC) vaccines so far...
  29. ncbi request reprint The role of economic evaluation in vaccine decision making: focus on meningococcal group C conjugate vaccine
    Robert Welte
    Institute of Health Economics and Health Care Management, GSF National Research Center for Environment and Health, Neuherberg, Germany
    Pharmacoeconomics 23:855-74. 2005
    ..In order to improve the international comparability of such studies, firmer national and international modelling guidelines and better adherence to such guidelines seem necessary...